Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Denmark France Germany Italy +5
  • Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

    Recruiting

    3 1 1
    Belgium Bulgaria Denmark Finland Germany Hungary +5
  • Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

    Recruiting

    3 1 1
    Czechia Denmark France Greece Hungary Poland +1
  • Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    Poland
  • Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

    Recruiting

    3 1
    Investigated Drugs:
    Bulgaria Czechia France Germany Hungary Italy +3
  • Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

    Recruiting

    3 1
    Austria Belgium France Germany Ireland Italy +4
  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Recruiting

    3 1 1
    Investigated Diseases:
    Czechia Denmark Germany Greece The Netherlands Poland +2
  • Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Greece Hungary +7
  • Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn’s Disease

    Recruiting

    2 1 1 1
    Poland
  • Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Bulgaria Czechia France Germany Hungary Italy +5